Replies to post #100403 on Amarantus Bioscience Holdings Inc (AMBS)

[Riskreturn168]

I am hoping I am wrong about MANF and management is sitting on some explosive partnership they haven't revealed yet...but are about to.
That is a possibility, although it is rare that Big Pharma partners with a pre-clinical drug.

Or, maybe Gerald will perform some "financial engineering" in May to keep the stock price from spiraling down.

Or maybe John will surprise us with some Phenoguard and J&J relationship that pays us up front money? It's possible.

Other than one of these hopes, it is LymPro that must get us out of this hole we are in at .068 cents. But Gerald seemed tentative about the timing of commercialization, other than before Dec. 31st, and the time frame on up listing.

While the CC was filled with many great long term news, the news that could up list us this summer in 2014 seems to be fading....except LymPro. I'm counting on it bailing us out by July.

[sharpei]

In which case I hope they have learned to not invest in micro caps since this experience is common in these small stocks. The possibility that these stocks will turn when least expected is just as common.